Category Multilateral Fora

Implementing User Rights for Research in the Field of Artificial Intelligence: A Call for International Action

[Sean Flynn, Christophe Geiger, João Quintais, Thomas Margoni, Matthew Sag, Lucie Guibault and Michael W. Carroll.] Abstract: Last year, before the onset of a global pandemic highlighted the critical and urgent need for technology-enabled scientific research, the World Intellectual Property Organization (WIPO) launched an inquiry into issues at the intersection of intellectual property (IP) and artificial intelligence (AI). We contributed comments to that inquiry, with a focus on the application of copyright to the use of text and data mining (TDM) technology. This article describes some of the most salient points of our submission and concludes by stressing the need for international leadership on this important topic. WIPO could help fill the current gap on international leadership, including by providing guidance on the diverse mechanisms that countries may use to authorize TDM research and serving as a forum for the adoption of rules permitting cross-border TDM projects.

UNAIDS supports a temporary WTO waiver from certain obligations of the TRIPS Agreement in relation to the prevention, containment and treatment of COVID-19

[UNAIDS Press Statement] Today, the World Trade Organization’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council meets to consider a proposal presented by the Governments of South Africa and India for a temporary waiver of certain TRIPS obligations in order to facilitate an appropriate response to COVID-19. The aim is to create certainty and clarity, guaranteeing freedom to operate, innovate, procure and scale up manufacturing capacities in essential health technologies at the required scale. The waiver would reduce transaction costs and eliminate key barriers across the research and development cycle and the supply chain for the access and delivery of health technologies to prevent, diagnose and treat COVID-19.

TRIPS Flexibilities on Patent Enforcement: Lessons from Some Developed Countries Relating to Pharmaceutical Patent Protection

[Joshua Sarnoff] Authority for national judiciaries to issue permanent and preliminary injunctions is required by the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), Articles 44 and 50. But the TRIPS Agreement does not require the issuance of injunctions in any particular circumstances, and does not harmonize the laws on which national jurisdictions derive their injunctive relief authorities. Thus, countries remain free to refuse prohibitory injunctive relief for adjudicated or likely patent infringement, particularly if “reasonable compensation” is offered in the form of an “ongoing royalty” or an “interim royalty” payment, which acts similarly to a compulsory license.

Chilean Congress Supports INDIA and South Africa request at TRIPS COUNCIL

Today the Camara de Diputados ( House of Representatives) of Chile approved a resolution asking the Chilean government to support at the TRIPS council the moratoria of the trips obligations regard to vaccines and therapies for Covid in the terms proposed by India and South Africa. The resolution also request further support on the implementation of C - TAP.

Letter to President Ramaphosa on the Proposed Covid-19 Waiver, by 43 South Africa and India at the WTO, From South Africa-Affiliated Academics, Researchers and Teachers

South Africa, along with India, has adopted a ground-breaking position at the World Trade Organisation (WTO) with the tabling of the proposal for a “Waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19”. The proposal will be on the agenda of the WTO TRIPS Council on 15-16 October 2020. As a group of academics, researchers and teachers affiliated to various South African institutions, we declare our strong support for this proposal.

South Africa and India’s Proposal to Waive Recognition and Enforcement of Intellectual Property Rights for COVID-19 Medical Technologies Deserves Universal Support, But Countries Also Have to Take Domestic Measures

On October 2, India and South Africa petitioned the World Trade Organization (WTO) to allow all WTO members to bypass granting or enforcement of patents, trade secrets, industrial designs, and copyrights on COVID-19-related drugs, vaccines, diagnostics and other medical technologies for the duration of the pandemic – until global ‘herd immunity’ is achieved. The proposed “Waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19” should be promptly and emphatically supported by governments, international institutions, global health initiatives, and all of civil society—from health workers, to academics, and access-to-medicines activists.

Multilateral Matters #7: The draft Protocol on Intellectual Property Rights to the African Continental Free Trade Agreement (AfCFTA): Annotations on Genetic Resources, Traditional Knowledge and Cultural Expressions

[Wend Wendland] The continent-wide free trade zone created by the Agreement Establishing the African Continental Free Trade Area (the AfCFTA) has the potential to catalyse intra-African trade, boost economic development and lift tens of millions of Africans out of poverty. From a trade and development perspective, the AfCFTA advances a fresh trade model focused on inclusive and sustainable development. In recognizing the centrality of intellectual property (IP) protection in today’s economy, and the benefits of continental cooperation on IP, the AfCFTA will include a Protocol on IP, an early draft of which has been published. Finalization of the IP Protocol holds the promise of a home-grown, single, coherent and Africa-centred IP regime. This could harmonize the fragmented IP landscape of today while safeguarding national policy space on key issues, strengthen the hands of African negotiators in international forums and even help propel currently deadlocked international negotiations towards the finish line. This blog post examines the elements of the draft Protocol related to genetic resources, traditional knowledge and traditional cultural expressions (expressions of folklore). It is too soon to tell whether the IP Protocol will realise its promise and advance the policy objectives, principles and transformative potential of the AfCFTA. Future drafts of the Protocol will be followed closely by “Multilateral Matters”.

Action at the WTO is needed to accelerate research, development, manufacturing and supply of medical products to combat Covid-19: Proposal from India and South Africa

[Viviana Munoz Tellez] India and South Africa are calling for the WTO Members to agree to waive some of the obligations on protection and enforcement of patents and other intellectual property rights during the Covid-19 pandemic. The South Centre encourages all WTO Members to support the proposal in the upcoming TRIPS Council meeting on 10-11 October 2020 to forward a request to the General Council for the adoption of the decision text.

The TRIPS Council on 15-16 October should agree to extend the transition period that exempts Least Developed Countries from implementation of the WTO TRIPS Agreement

[Nirmalya Syam] The least developed country (LDC) members of the World Trade Organization (WTO) have submitted a request to the upcoming session of the TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) Council for an extension of the transition period available to LDC members under Article 66.1 of the TRIPS Agreement, for as long as they remain LDCs, and for an additional period of 12 years following their official graduation from the LDC category as determined by the United Nations (UN) General Assembly.

Implementing the Marrakesh Treaty in Latin America: A Look at the Experiences of Four CC Community Members

[Brigitte Vézina and Scann] Four years ago today, the Marrakesh Treaty entered into force. The Treaty is truly special in the international copyright law universe: it has a clear humanitarian and social development dimension and it’s the first international treaty that focuses on the beneficiaries of limitations and exceptions, rather than on the rights of creators or holders of related rights. Adopted at the World Intellectual Property Organization (WIPO) in 2013, the Marrakesh Treaty’s main goal is to create a set of mandatory limitations and exceptions for the benefit of the blind, visually impaired, and otherwise print disabled (VIPs). The Marrakesh Treaty is a huge step forward for VIPs around the world, as it facilitates access to works in adapted versions. However, making sure the treaty works on the ground in each country or institution is not necessarily plain sailing.

WTO TRIPS Council Discusses National IP Measures and TRIPS Flexibilities in the Context of COVID-19

[Nirmalya Syam] A regular session of the TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) Council was held virtually on 30 July 2020. This session offered the first opportunity for the World Trade Organization (WTO) Members to discuss intellectual property (IP) related issues in the context of COVID-19. Discussions focused on national measures taken by various countries in relation to IP in response to COVID-19 as well as the scope of the use of TRIPS flexibilities across the spectrum of various IP rights in order to ensure rapid development, scaled up manufacturing of and affordable, timely and equitable access to various technologies and products required to respond to COVID-19. South Africa made a strong general statement pointing to the need to consider new bold measures that will comprehensively and expeditiously address IP challenges.

WHO, WIPO, WTO launch updated study on access to medical technologies and innovation

[World Intellectual Property Organization press release] On 29 July, the Directors-General of the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation. Building on the first edition launched in 2013, the publication seeks to strengthen the understanding of the interplay between the distinct policy domains of health, trade and intellectual property (IP), and how they affect innovation and access to medical technologies, such as medicines, vaccines and medical devices. The second edition provides an improved, evidence-based foundation for policy debate and informed decision-making at a critical time for global health.